Geode Capital Management
HRMY icon

Geode Capital Management’s Harmony Biosciences HRMY Stock Holding History

Geode Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.5M Buy
1,442,649
+119,929
+9% +$3.78M ﹤0.01% 1598
2026
Q1 		$37.1M Buy
1,322,720
+52,134
+4% +$1.71M ﹤0.01% 1661
2025
Q4 		$47.6M Buy
1,270,586
+12,323
+1% +$405K ﹤0.01% 1512
2025
Q3 		$34.7M Buy
1,258,263
+203,915
+19% +$7.02M ﹤0.01% 1702
2025
Q2 		$33.3M Buy
1,054,348
+88,598
+9% +$2.85M ﹤0.01% 1659
2025
Q1 		$32.1M Buy
965,750
+62,816
+7% +$2.25M ﹤0.01% 1635
2024
Q4 		$31.1M Buy
902,934
+167,516
+23% +$5.76M ﹤0.01% 1715
2024
Q3 		$29.4M Sell
735,418
-13,285
-2% -$467K ﹤0.01% 1769
2024
Q2 		$22.6M Sell
748,703
-5,074
-0.7% -$153K ﹤0.01% 1866
2024
Q1 		$25.3M Buy
753,777
+14,872
+2% +$477K ﹤0.01% 1779
2023
Q4 		$23.9M Buy
738,905
+19,529
+3% +$545K ﹤0.01% 1805
2023
Q3 		$23.6M Buy
719,376
+58,070
+9% +$2.02M ﹤0.01% 1719
2023
Q2 		$23.3M Buy
661,306
+87,681
+15% +$3.03M ﹤0.01% 1753
2023
Q1 		$18.7M Buy
573,625
+23,384
+4% +$1.06M ﹤0.01% 1846
2022
Q4 		$30.3M Buy
550,241
+19,957
+4% +$1.1M ﹤0.01% 1486
2022
Q3 		$23.5M Buy
530,284
+61,465
+13% +$3M ﹤0.01% 1614
2022
Q2 		$22.9M Buy
468,819
+27,205
+6% +$1.22M ﹤0.01% 1671
2022
Q1 		$21.5M Buy
441,614
+16,786
+4% +$685K ﹤0.01% 1855
2021
Q4 		$18.1M Buy
424,828
+13,718
+3% +$547K ﹤0.01% 2018
2021
Q3 		$15.8M Buy
411,110
+186,168
+83% +$5.99M ﹤0.01% 2126
2021
Q2 		$6.35M Buy
224,942
+124,185
+123% +$3.73M ﹤0.01% 2762
2021
Q1 		$3.33M Buy
100,757
+9,357
+10% +$328K ﹤0.01% 2986
2020
Q4 		$3.3M Buy
91,400
+44,904
+97% +$1.81M ﹤0.01% 2823
2020
Q3 		$1.58M Buy
+46,496
New +$1.7M ﹤0.01% 3003

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management's HRMY Position: Q2 2026 in Review

Geode Capital Management increased its Harmony Biosciences (HRMY) stake by 9.1% in Q2 2026, buying an estimated $3.78M and bringing the position to 1,442,649 shares worth $52.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1598.

Geode Capital Management first reported a position in HRMY in Q3 2020 and has held it in 24 quarters since. 301 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Geode Capital Management held 1,442,649 shares of Harmony Biosciences worth $52.5M as of Q2 2026.
  • Geode Capital Management bought 119,929 Harmony Biosciences shares in Q2 2026, an estimated $3.78M.
  • Harmony Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1598 holding.
  • Geode Capital Management first reported a position in Harmony Biosciences in Q3 2020 and has held it in 24 quarters since.
  • 301 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.